Dimensional Fund Advisors
CTKB icon

Dimensional Fund Advisors’s Cytek Biosciences CTKB Stock Holding History

Dimensional Fund Advisors’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Sell
2,616,257
-47,072
-2% -$201K ﹤0.01% 2253
2026
Q1 		$11.6M Buy
2,663,329
+16,438
+0.6% +$77.6K ﹤0.01% 2200
2025
Q4 		$13.4M Sell
2,646,891
-570,897
-18% -$2.65M ﹤0.01% 2179
2025
Q3 		$11.2M Sell
3,217,788
-237,018
-7% -$890K ﹤0.01% 2264
2025
Q2 		$11.7M Buy
3,454,806
+600,997
+21% +$2M ﹤0.01% 2216
2025
Q1 		$11.4M Buy
2,853,809
+1,023,377
+56% +$5.3M ﹤0.01% 2193
2024
Q4 		$11.9M Buy
1,830,432
+262,607
+17% +$1.56M ﹤0.01% 2238
2024
Q3 		$8.68M Buy
1,567,825
+102,703
+7% +$582K ﹤0.01% 2357
2024
Q2 		$8.17M Buy
1,465,122
+89,615
+7% +$538K ﹤0.01% 2339
2024
Q1 		$9.23M Buy
1,375,507
+311,174
+29% +$2.46M ﹤0.01% 2340
2023
Q4 		$9.71M Buy
1,064,333
+153,592
+17% +$967K ﹤0.01% 2330
2023
Q3 		$5.03M Buy
910,741
+570,509
+168% +$4.58M ﹤0.01% 2529
2023
Q2 		$2.9M Buy
340,232
+176,695
+108% +$1.58M ﹤0.01% 2683
2023
Q1 		$1.5M Buy
+163,537
New +$1.76M ﹤0.01% 2810

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Dimensional Fund Advisors's CTKB Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Cytek Biosciences (CTKB) stake by 1.8% in Q2 2026, selling an estimated $201K and leaving 2,616,257 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2253.

Dimensional Fund Advisors first reported a position in CTKB in Q1 2023 and has held it in 14 quarters since. The position peaked at $13.4M in Q4 2025. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Dimensional Fund Advisors held 2,616,257 shares of Cytek Biosciences worth $11.6M as of Q2 2026.
  • Dimensional Fund Advisors sold 47,072 Cytek Biosciences shares in Q2 2026, an estimated $201K.
  • Cytek Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2253 holding.
  • Dimensional Fund Advisors first reported a position in Cytek Biosciences in Q1 2023 and has held it in 14 quarters since.
  • Dimensional Fund Advisors's Cytek Biosciences position peaked at $13.4M in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.